Our second patient had a heterozygous mutation c.3295G>T (p.Glu1099*) of the SCN1A gene (see Table 1), this mutation was already identified in patients showing Dravet syndrome [14]. This evidence concerns the gene SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.